National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

anti-IL-6 chimeric monoclonal antibody (AN-tee ... ky-MEER-ik MAH-noh-KLOH-nul AN-tee-BAH-dee)

 A chimeric (made from human and mouse proteins) monoclonal antibody being studied in the treatment of advanced kidney cancer and other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-IL-6 chimeric monoclonal antibody works by blocking inflammation and tumor growth. Also called cCLB8 and CNTO 328.



Previous Definitions:anti-CD22 immunotoxin CAT-8015, anti-CD45 monoclonal antibody, anti-CEA antibody, anti-EpCAM-Pseudomonas-exotoxin fusion protein, anti-idiotype vaccine
Next Definitions:anti-inflammatory, anti-mesothelin monoclonal antibody MORAb-009, anti-TGF-beta monoclonal antibody GC1008, anti-VEGFR monoclonal antibody, antiandrogen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov